Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Re Agreement

13 Aug 2007 07:00

Embargoed Release: 07:00hrs Monday 13 August 2007

SOPHEON PLC ("Sopheon") SOPHEON NAMED TO ENABLE TRANSITION OF IDe CUSTOMERS Arrangement Extends Sopheon's Position as Industry's Leading Provider of Product Roadmapping, Planning and Process Automation Solutions

Sopheon plc announces today that its affiliate, Sopheon Corporation, has entered into an agreement with Integrated Development Enterprise, Inc. ("IDe") under which Sopheon intends to offer transition services and support to IDe customers previously covered by IDe maintenance and support contracts. The agreement follows a recent decision by IDe to discontinue its business.

Founded in 1998, Boston-based IDe specialized in providing product portfolio management software solutions to large manufacturers and services companies. IDe has announced Sopheon, a former competitor, to its customers as an alternate source of services and assistance that IDe will no longer be able to provide.

Terms of the agreement afford Sopheon exclusive access to such IDe assets as its customer list, software code and all documentation relating to IDe's software. Sopheon intends to contact each of IDe's customers to discuss potential support options, including transitioning to Sopheon's Accolade‚® software and services. However, Sopheon is not committed to assume, nor is it legally bound to, any of IDe's obligations to IDe's former end-users, and terms and conditions of the transition will be as agreed between Sopheon and IDe's individual customers. IDe's client base of 18 companies is approximately one-fifth the size of Sopheon's and similarly includes many Fortune 1000 companies.

Sopheon's outreach to IDe customers began last week. Sopheon said that it views the initiative as a unique opportunity to expand its customer population while also increasing maintenance and support revenue.

Less than 60 days ago, Sopheon was successful in a bid to acquire the assets of Alignent Software, a California-based supplier of advanced product and technology roadmapping solutions. The consolidation of Alignent enabled Sopheon to extend its product life cycle management solution footprint to include product planning. Sopheon believes that the agreement with IDe will build on Sopheon's history of steady, substantial growth in the expanding product portfolio and innovation process management market. Since Sopheon's launch of its Accolade solution six years ago, its Accolade-related revenues in dollar terms have increased at an average rate of nearly 50% per year.

Barry Mence, chairman of Sopheon, commented:

"There is good compatibility between IDe's flagship offering and Sopheon's Accolade. There is also a strong fit between our client bases. Add to this the fact that we already know a fair amount about IDe's application, and we believe we are in a position to offer a seamless transition to IDe customers."

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO David Newton Seymour Pierce Limited Tel: +44 (0) 207 107 8000 Jonathan Wright, Nominated Advisers Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's Accolade system automates and governs the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.